Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.

Related Articles

Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.

Front Pharmacol. 2016;7:299

Authors: Thompson MD, Capra V, Clunes MT, Rovati GE, Stankova J, Maj MC, Duffy DL

Abstract
Genetic variants associated with asthma pathogenesis and altered response to drug therapy are discussed. Many studies implicate polymorphisms in genes encoding the enzymes responsible for leukotriene synthesis and intracellular signaling through activation of seven transmembrane domain receptors, such as the cysteinyl leukotriene 1 (CYSLTR1) and 2 (CYSLTR2) receptors. The leukotrienes are polyunsaturated lipoxygenated eicosatetraenoic acids that exhibit a wide range of pharmacological and physiological actions. Of the three enzymes involved in the formation of the leukotrienes, arachidonate 5 lipoxygenase 5 (ALOX5), leukotriene C4 synthase (LTC4S), and leukotriene hydrolase (LTA4H) are all polymorphic. These polymorphisms often result in variable production of the CysLTs (LTC4, LTD4, and LTE4) and LTB4. Variable number tandem repeat sequences located in the Sp1-binding motif within the promotor region of the ALOX5 gene are associated with leukotriene burden and bronchoconstriction independent of asthma risk. A 444A > C SNP polymorphism in the LTC4S gene, encoding an enzyme required for the formation of a glutathione adduct at the C-6 position of the arachidonic acid backbone, is associated with severe asthma and altered response to the CYSLTR1 receptor antagonist zafirlukast. Genetic variability in the CysLT pathway may contribute additively or synergistically to altered drug responses. The 601 A > G variant of the CYSLTR2 gene, encoding the Met201Val CYSLTR2 receptor variant, is associated with atopic asthma in the general European population, where it is present at a frequency of ?2.6%. The variant was originally found in the founder population of Tristan da Cunha, a remote island in the South Atlantic, in which the prevalence of atopy is approximately 45% and the prevalence of asthma is 36%. In vitro work showed that the atopy-associated Met201Val variant was inactivating with respect to ligand binding, Ca(2+) flux and inositol phosphate generation. In addition, the CYSLTR1 gene, located at Xq13-21.1, has been associated with atopic asthma. The activating Gly300Ser CYSLTR1 variant is discussed. In addition to genetic loci, risk for asthma may be influenced by environmental factors such as smoking. The contribution of CysLT pathway gene sequence variants to atopic asthma is discussed in the context of other genes and environmental influences known to influence asthma.

PMID: 27990118 [PubMed – in process]

View full post on pubmed: asthma

Black Children Hit Harder By Asthma, But Underrepresentation In Studies Leaves Researchers At A Loss – California Healthline

Black Children Hit Harder By Asthma, But Underrepresentation In Studies Leaves Researchers At A Loss
California Healthline
Black Children Hit Harder By Asthma, But Underrepresentation In Studies Leaves Researchers At A Loss. Black children are 10 times more likely than white kids to die of complications from asthma, and scientists want to find genetic clues that may have

View full post on asthma – Google News

Teva’s asthma candidates successful in three late-stage studies; regulatory … – Seeking Alpha

Teva's asthma candidates successful in three late-stage studies; regulatory
Seeking Alpha
Top-line results from three Phase 3 clinical trials assessing Teva Pharmaceutical Industries' (TEVA +0.4%) fluticasone propionate/salmeterol, a combination inhaled corticosteroid and long-acting beta agonist delivered via a multidose dry powder inhaler

View full post on asthma – Google News

Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis – Medscape

Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis
Medscape
Montelukast was approved by the Food and Drug Administration (FDA) on February 20, 1998 for the treatment of asthma in children and adults. It has gained widespread acceptance as an adjunct to inhaled corticosteroids and beta-adrenergic agonists in the …

View full post on asthma – Google News

Chubby babies are more likely to suffer from asthma, new studies reveals – Mirror.co.uk


Mirror.co.uk

Chubby babies are more likely to suffer from asthma, new studies reveals
Mirror.co.uk
Babies that put on weight rapidly in their first three months are more likely to suffer from asthma later. Researchers believe quickly gaining weight may lead to abnormal development of the child's lungs or immune system. The Bristol University team
Early weight gain 'ups asthma risk'Belfast Telegraph

all 11 news articles »

View full post on asthma – Google News

New studies link asthma to higher risk of heart disease – Milwaukee Journal Sentinel


Medical Xpress

New studies link asthma to higher risk of heart disease
Milwaukee Journal Sentinel
People who are treated for asthma are at substantially higher risk of developing cardiovascular disease, according to two research papers presented Sunday. However, researchers don't know whether it is asthma or asthma medications that are behind the …
Asthma Raises Heart Attack Risk, Research SuggestsU.S. News & World Report
Patients with active asthma at higher risk for heart attack, research showsMedical Xpress
Asthma May Put the Heart in PerildailyRx
HealthCanal.com
all 17 news articles »

View full post on asthma – Google News

Teva’s Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies – RTT News

Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies
RTT News
Teva Pharmaceutical Industries Ltd. (TEVA: Quote) announced that reslizumab, an investigational anti-IL-5 monoclonal antibody, demonstrated clear levels of efficacy in achieving the primary endpoint of reduction in the frequency of clinical asthma …

and more »

View full post on asthma – Google News